Amprius Raises $25M to Commercialize Next-Generation Lithium Ion Batteries for Electric Vehicles

Amprius has raised $25 million to commercialize next generation lithium ion batteries leveraging Amprius’ proprietary silicon-based electrode technology. Major new investors include IPV Capital (Shanghai, China), Kleiner Perkins Caufield & Byers (Menlo Park, CA), and Qian Neng Fund (Wuxi, China). Also participating in this round are previous investors Trident Capital, VantagePoint Venture Partners, Dr. Eric Schmidt, and Stanford University.

“Our recent fundraising will enable us to deploy our first commercial product, validate our manufacturing processes, and launch a global presence”

Amprius is commercializing high energy, silicon-based materials to enable next generation lithium-ion batteries. Amprius-enabled cells will ultimately offer a dramatic increase in energy, substantially increasing range and runtime for applications including consumer electronics and electric vehicles. Amprius’ technology has recently achieved key validation milestones for consumer electronics applications such as smartphones and continues to advance toward requirements necessary for electric drive vehicle applications.

“Our recent fundraising will enable us to deploy our first commercial product, validate our manufacturing processes, and launch a global presence,” said to Dr. Kang Sun, CEO of Amprius. “We are delighted to have the support of new investors and the continued support of current investors as we embark on the next phase of our business.”

Amprius was founded by Professor Yi Cui from Stanford University in May 2008 with the mission to develop and commercialize advanced materials and nanotechnology for improved energy storage. The Amprius team has more than 50 years of experience in the battery, materials and manufacturing areas, including world-class experts in electrochemistry, nanotechnology and large-scale silicon film manufacturing. Headquartered in Menlo Park, California, Amprius is funded by Trident Capital, VantagePoint Venture Partners, IPV Capital, Kleiner Perkins Caufield & Byers and Qian Neng Fund, Dr. Eric Schmidt, and Stanford University.

www.amprius.com